ArticleFrontiers in oncology2023

Anlotinib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma associated with hepatitis B virus: a retrospective controlled study.

Song Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.